Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship

OBJECTIVES: We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial. METHODS: Participants were randomly selected to receive either nevirapine at 200 mg twice d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Bhatt, Nilesh B., Baudin, Elisabeth, Meggi, Bindiya, da Silva, Carlota, Barrail-Tran, Aurélie, Furlan, Valérie, Grinsztejn, Beatriz, Bonnet, Maryline, Taburet, Anne-Marie, Jani, Ilesh V., Sitoe, Nádia, Vubil, Adolfo, Nhadzombo, Maria, Sitoe, Fernando, Nhumaio, Delário, Bule, Odete, Cossa, Kátia, Bastos, Rui, Nunes, Elizabete, Gudo, Paula Samo, Lima, Josué, Okamura, Mie, Ciaffi, Laura, Sobry, Agnès, Lugli, Mariano, Lab, Bruno, Barreto, Avertino, Michon, Christophe, Calmy, Alexandra, Diallo, Alpha, Rouzioux, Christine
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267502/
https://ncbi.nlm.nih.gov/pubmed/25239466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dku348
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars